Kuraci
1 products tracked · names used in filings: Kuraci
Upcoming milestones
Mon 18 Jan 2027🇪🇺 Expected EC decisionestimatein 65 days
Donrafylix (insulin aspart): expected EC decision
Estimated as CHMP opinion (2026-11-12) + 67 days, the standard Commission decision period. Not an official date. · Kuraci · source
Recent milestones
Thu 12 Nov 2026🇪🇺 CHMP positive opinion
Donrafylix (insulin aspart): CHMP positive opinion
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Donrafylix insulin aspart | Opinion |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.